Roger Tung is the founder of Concert Pharmaceuticals. Latest round: Series A. Backed by Three Arch Partners, TVM Capital, Skyline Ventures.
Roger D. Tung is the Co-Founder, President, and CEO of Concert Pharmaceuticals, a clinical-stage biopharmaceutical company focused on developing small-molecule drugs for autoimmune diseases. He is also involved in the broader biopharma sector, having been appointed to the board of directors of Flex Pharma, Inc.
Full founder directory · Investor directory · Company funding database · Fundraising library